ETFs Repligen Corporation

RGEN

US7599161095

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 00:00:00 29/10/2026 +04			5-day change	1st Jan Change
184.69 ^USD	+5.06%		+2.60%	+12.71%

10-28	RBC Raises Price Target on Repligen to $200 From $185, Keeps Outperform Rating	MT
10-27	Repligen Corporation Reports Intangible Asset Impairment Charges for the Third Quarter Ended September 30, 2026	CI

ETFs positioned on Repligen Corporation

Name	YTD change	Weight	AuM
STATE STREET SPDR S&P MIDCAP 400 ETF TRUST - USD	+10.88%	-	27,376 M€
UBS MSCI USA SELECT FACTOR MIX UCITS ETF (HEDGED TO CHF) A-ACC - CHF	+9.15%	-	28 M€
FUNDX CONSERVATIVE ETF - USD	+6.23%	-	49 M€
FUNDX FLEXIBLE ETF - USD	+0.94%	-	51 M€
STATE STREET SPDR S&P 400 MID CAP GROWTH ETF - USD	+12.53%	-	2,959 M€
DIMENSIONAL WORLD EQUITY ETF - USD	+13.44%	-	1,674 M€
ISHARES MORNINGSTAR SMALL-CAP ETF - USD	+11.71%	-	292 M€
BNP PARIBAS EASY BNP PARIBAS EASY MSCI WORLD MIN TE UCITS ETF - EUR	+18.13%	-	750 M€
FIRST TRUST NYSE ARCA BIOTECHNOLOGY UCITS ETF - ACC - USD	+34.19%	3.33%	16 M€
FIRST TRUST NYSE ARCA BIOTECHNOLOGY INDEX FUND ETF - USD	+35.34%	3.32%	2,809 M€
INVESCO DYNAMIC BIOTECHNOLOGY & GENOME ETF - USD	+24.00%	2.25%	379 M€
CONGRESS SMID GROWTH ETF - USD	+10.28%	2.07%	488 M€
ISHARES HEALTH INNOVATION ACTIVE ETF - USD	+19.18%	1.76%	13 M€
GOLDMAN SACHS FUTURE HEALTH CARE EQUITY ETF - USD	+7.47%	1.32%	20 M€
VANECK BIOTECH ETF - USD	+33.82%	1.04%	429 M€
GOLDMAN SACHS SMALL CAP CORE EQUITY ETF - USD	+16.76%	0.88%	297 M€
FIDELITY DISRUPTIVE MEDICINE ETF - USD	+22.87%	0.86%	49 M€
ISHARES HEALTHCARE INNOVATION UCITS ETF - USD	+28.08%	0.8%	1,260 M€
WISDOMTREE BIOREVOLUTION UCITS ETF ACC USD	+52.08%	0.8%	24 M€
AMPLIFY AI POWERED EQUITY ETF - USD	+8.58%	0.78%	124 M€
ISHARES BIOTECHNOLOGY ETF - USD	+28.19%	0.61%	9,953 M€
XTRACKERS WORLD SMALL CAP GREEN TECH INNOVATORS UCITS ETF 1C - USD	+21.28%	0.6%	87 M€
FIRST TRUST MULTI-MANAGER SMALL CAP OPPORTUNITIES ETF - USD	+12.26%	0.54%	54 M€
XTRACKERS MSCI GENOMIC HEALTHCARE INNOVATION UCITS ETF 1C - USD	+36.59%	0.44%	11 M€
UBS MSCI WORLD SMALL CAP SOCIALLY RESPONSIBLE UCITS ETF (USD) A-ACC - USD	+15.55%	0.38%	758 M€
XTRACKERS S&P MIDCAP 400 SCORED & SCREENED ETF - USD	+12.44%	0.33%	4 M€
MOTLEY FOOL NEXT INDEX ETF - USD	+15.03%	0.32%	34 M€
VANGUARD MORNINGSTAR SMALL-CAP GROWTH ETF - USD	+11.48%	0.31%	24,702 M€
UBS MSCI WORLD SMALL CAP SOCIALLY RESPONSIBLE UCITS ETF (USD) A-DIS - USD	+10.19%	0.29%	81 M€
AMPLIFY ETHO CLIMATE LEADERSHIP U.S. ETF - USD	+24.11%	0.29%	195 M€
INTECH S&P SMALL-MID CAP DIVERSIFIED ALPHA ETF - USD	+14.54%	0.27%	135 M€
STATE STREET SPDR S&P 400 U.S. MID CAP UCITS ETF - USD	+10.29%	0.27%	6,769 M€

1 2 3 4 5

Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. Its franchises include filtration, chromatography, process analytics and proteins. Its filtration franchise includes product offering covering upstream and downstream technologies. Its filtration products include XCell Alternating Tangential Flow (ATF) Cell Retention Systems, Flat Sheet Cassettes, Hollow Fiber Consumables, Tangential Flow Filtration Systems and Fluid Management. Its chromatography franchise includes products used in downstream purification, development, manufacturing and quality control of biological drugs. Its chromatography franchise includes OPUS Pre-Packed Columns, KRM Chromatography Systems and other additional chromatography products. Its process analytics include Downstream process analytical technology (PAT) and Upstream PAT. Its Proteins include Protein A Affinity Ligands, AVIPure Resins for New Modalities and Growth Factors.

Employees

2,000

Sector

Medical Equipment, Supplies & Distribution

More about the company